medigraphic.com

2018, Número 5

<< Anterior Siguiente >>

Cir Cir 2018; 86 (5)


Carcinoma neuroendocrino indiferenciado polimetástatico altamente agresivo de células pequeñas de colon ascendente

Ioannidis O, Chatzidelios C, Mantzoros I, Tatsis D, Kitsikosta L, Chatzakis C, Makrantonakis A, Paraskevas G, Kotidis E, Pramateftakis MG, TsalisK

Idioma: Ingles.
Referencias bibliográficas: 21
Paginas: 446-449
Archivo PDF: 257.17 Kb.


RESUMEN

El carcinoma neuroendocrino del colon es un tumor raro y muy agresivo, con mal pronóstico. Se presenta el caso de un hombre de 53 años con un carcinoma de colon ascendente de 6 × 10 cm que causa obstrucción del intestino grueso, con metástasis hepáticas múltiples simultáneas y carcinomatosis peritoneal. Se realizó la resección quirúrgica del tumor primario, debido a la obstrucción intestinal, para mejorar los síntomas antes del inicio de la quimioterapia. La histopatología reveló que el tumor era un carcinoma neuroendocrino indiferenciado de células pequeñas. Durante el posoperatorio, el paciente presentó metástasis pulmonares y el día 36 posoperatorio se produjo la muerte por insuficiencia respiratoria. Palabras clave: Tumor neuroendocrino. Cromogranina. Enolasa específica de neuronas. Colectomía.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Jones K, Subramaniam RM, Durnick DK, Peller PJ. F-18-FDG-PET/CT imaging of small cell carcinoma of the colon. Clin Nucl Med 2008;33:645‑6. doi: 10.1097/RLU.0b013e31818130c5.

  2. Kim HC, Park SI, Park SJ, et al. Small cell carcinoma of the colon: barium study and CT findings. Br J Radiol 2005;78:255-6.

  3. Park JS, Kim L, Kim CH, et al. Synchronous large-cell neuroendocrine carcinoma and adenocarcinoma of the colon. Gut Liver 2010;4:122-5. doi: 10.5009/gnl 2010.4.1.122.

  4. Shafqat H, Ali S, Salhab M, Olszewski AJ. Survival of patients with neuroendocrine carcinoma of the colon and rectum: a population-based analysis. Dis Colon Rectum 2015;58:294-303. doi: 10.1097/ DCR.0000000000000298.

  5. Miyamoto H, Kurita N, Nishioka M, et al. Poorly differentiated neuroendocrine cell carcinoma of the rectum: report of a case and literal review. J Med Invest 2006;53:317-20.

  6. Shia J, Tang LH, Weiser MR, et al. Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity? Am J Surg Pathol 2008;32:719-31. doi: 10.1097/PAS. 0b013e318159371c.

  7. Yaziji H, Broghamer WL Jr. Primary small cell undifferentiated carcinoma of the rectum associated with ulcerative colitis. South Med J 1996;89:921‑4.

  8. Grabowski P, Schönfelder J, Ahnert-Hilger G, et al. Expression of neuroendocrine markers: a signature of human undifferentiated carcinoma of the colon and rectum. Virchows Arch 2002;441:256-63.

  9. Grabowski P, Schönfelder J, Ahnert-Hilger G, et al. Heterogeneous expression of neuroendocrine marker proteins in human undifferentiated carcinoma of the colon and rectum. Ann N Y Acad Sci 2004;1014:270-4.

  10. Kato T, Terashima T, Tomida S, et al. Cytokeratin 20-positive large cell neuroendocrine carcinoma of the colon. Pathol Int 2005;55:524-9.

  11. Onoda N, Kobayashi H, Satake K, et al. Neuroendocrine carcinoma of the sigmoid colon: report of a case. Surg Today 1999;29:1079-82.

  12. Gaffey MJ, Mills SE, Lack EE. Neuroendocrine carcinoma of the colon and rectum. A clinicopathologic, ultrastructural, and immunohistochemical study of 24 cases. Am J Surg Pathol 1990;14:1010-23.

  13. Yasui O, Tsukamoto F, Kudo K. Small cell undifferentiated carcinoma of the ascending colon with rapid enlargement after resection: report of a case and review of the literature. Tohoku J Exp Med 2006;209:361‑7.

  14. Matsuda A, Sasajima K, Matsutani T, et al. Aggressive undifferentiated colon carcinoma producing granulocyte-colony stimulating factor: report of a case. Surg Today 2009;39:990-3. doi: 10.1007/s00595-008‑3941‑1.

  15. Power DG, Asmis TR, Tang LH, Brown K, Kemeny NE. High-grade neuroendocrine carcinoma of the colon, long-term survival in advanced disease. Med Oncol 2011;28 Suppl 1:S169-74. doi: 10.1007/s12032-010- 9674-1.

  16. Ramage JK, Davies AH, Ardill J, et al. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours. Gut. 2005;54 Suppl 4:iv1-16.

  17. Pascarella MR, McCloskey D, Jenab-Wolcott J, Vala M, Rovito M, McHugh J. Large cell neuroendocrine carcinoma of the colon: A rare and aggressive tumor. J Gastrointest Oncol 2011;2:250-3. doi: 10 3978/j. issn.2078-6891.2011.026.

  18. Oberg K. Neuroendocrine tumors of the gastrointestinal tract: recent advances in molecular genetics, diagnosis, and treatment. Curr Opin Oncol 2005;17:386-91.

  19. Rifu K, Koinuma K, Horie H, et al. Sigmoid colon carcinoma with focal neuroendocrine differentiation associated with ulcerative colitis: A case report. Int J Surg Case Rep 2016;23:151-6. doi: 10.1016/j.ijscr. 2016.04.035.

  20. Reyes CV, Siddiqui MT. Anaplastic carcinoma of the colon: clinicopathologic study of eight cases of a poorly recognized lesion. Ann Diagn Pathol 1997;1:19-25.

  21. Mantzoros I, Savvala N, Ioannidis O, et al. Midgut neuroendocrine tumor presenting with acute intestinal ischemia. World J Gastroenterol 2017;23:8090-6. doi: 10.3748/wjg.v23 i45.8090




2020     |     www.medigraphic.com